Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol
Publication
, Conference
Richardson, PG; Smith, AR; Grupp, SA; Kernan, NA; Arai, S; Haut, PR; Triplett, BM; Gillio, AP; Symons, HJ; Adams, RH; Horn, BN; Lucas, K ...
Published in: BLOOD
November 18, 2011
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
226 / 227
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Richardson, P. G., Smith, A. R., Grupp, S. A., Kernan, N. A., Arai, S., Haut, P. R., … Soiffer, R. J. (2011). Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol. In BLOOD (Vol. 118, pp. 226–227). San Diego, CA: AMER SOC HEMATOLOGY.
Richardson, Paul G., Angela R. Smith, Stephan A. Grupp, Nancy A. Kernan, Sally Arai, Paul R. Haut, Brandon M. Triplett, et al. “Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol.” In BLOOD, 118:226–27. AMER SOC HEMATOLOGY, 2011.
Richardson PG, Smith AR, Grupp SA, Kernan NA, Arai S, Haut PR, et al. Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol. In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 226–7.
Richardson, Paul G., et al. “Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol.” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 226–27.
Richardson PG, Smith AR, Grupp SA, Kernan NA, Arai S, Haut PR, Triplett BM, Gillio AP, Symons HJ, Adams RH, Horn BN, Lucas K, Martin PL, Mineishi S, Ball ED, Boyer M, Fort J, Kirov II, Lehmann LE, Madigan C, Maglio ME, Massaro J, D’Agostino RB, Hannah AL, Tudone E, Hume R, Iacobelli M, Soiffer RJ. Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol. BLOOD. AMER SOC HEMATOLOGY; 2011. p. 226–227.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
226 / 227
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology